CMMC SYMPOSIUM

25 Years of Progress in Molecular Medicine:
From Basic Research to Clinical Application

Announcement

Over the last 25 years, medicine has undergone an impressive development and the understanding of the pathogenesis of diseases at the molecular and cellular level has contributed significantly to the development of specific tools for the diagnosis, treatment or prevention of diseases.

However, in recent years it has also become clear that a direct translation of current knowledge into new therapeutic options for the treatment of human diseases is more complex than originally thought. One reason for this is that the principles of disease development and practically all pathomechanisms - with the exception of some rare monogenetic diseases - are the result of complex, often overlapping changes. In addition to genetic aberrations and predispositions, epigenetics plays an important role in the development and progression of diseases as well as diverse environmental and nutritional influences and complex interlocking pathomechanisms. Genetic and epigenetic changes influence the finely tuned intracellular and intercellular signal transduction networks of cells, tissues and organs, which together constitute the communication system of the human organism.

In order to highlight and discuss these important developments, it is our great pleasure to announce the CMMC Symposium - 25 Years of Progress in Molecular Medicine: From Basic Research to Clinical Application taking place from September 26 - 28, 2021 in Cologne.

Stem Cell Biology and Regenerative Medicine:
Thomas Graf (Barcelona, ES) • Konrad Hochedlinger (Boston, US) • Rudolph Jaenisch (Cambridge, US) • Luigi Naldini (Milan, IT) • Lorenz Studer  (New York, US) • Fiona M Watt (London, GB)

Molecular Oncology and Genomic Medicine:
Peter Lichter (Heidelberg, DE) •  Núria López-Bigas (Barcelona, ES) • Stefan Pfister (Heidelberg, DE) • Sir Mike Stratton (Cambridge, GB) • Sarah Teichmann (Hinxton, GB)

Precision Medicine in Cancer Treatment:
Chris J Lord (London, UK) • Ari M. Melnick (New York, US) • Laura Pasqualucci (New York, US) • Dirk Schadendorf (Essen, DE) • Michael B Yaffe(Cambridge, US)

Infectious Diseases:
Ralf Bartenschlager (Heidelberg, DE) • Gülsah Gabriel (Hamburg, DE) •  Florian Klein (Cologne, DE) • Silvia Portugal (Berlin, DE) • Rino Rappuoli (Siena, IT) • Stephan Urban (Heidelberg, DE)

Neuroplasticity and Neurodegeneration:
Nils Brose  (Goettingen, DE) • Nadine Gogolla  (Munich, DE) •  Pascal S Kaeser  (Boston, US) •  Anne Schaefer  (New York, US) • Patrik Verstreken (Leuven, BE)

Metabolism and Aging:
Jens C Bruening (Cologne, DE) • Anne Brunet  (Stanford, US) • Andrew Dillin (Berkeley, US) • Cristina García Cáceres (Neuherberg, DE) • Lora Heisler (Aberdeen, GB)

Center for Molecular Medicine Cologne (CMMC) - University of Cologne

The CMMC organizers thank the Cologne Convention Bureau for their excellent support.
Further information: http://www.conventioncologne.de

Thomas Benzing | Jens Brüning | Reinhard Büttner | Claus Cursiefen | Michael Hallek | Thomas Krieg | Martin Krönke | Carien Niessen | Christian Reinhardt | Wilhelm Stoffel | Debora Grosskopf-Kroiher (CMMC-Organization)

CECAD Cologne - Cluster of Excellence  •  CRC 829  •  CRC 1218  •  CRC 1310  •  CRC 1399  •  CRC 1403  •  T-CRC 259  •  Research Unit 2240  •  Research Unit 2722  •  Clinical ResearchUnit 286  •  Clinical ResearchUnit 329  •  GSfBS  •  GSHZ  •  CGA  •  GS-Pharmakologie  •  IPMM  •  IPHS  •  Center for Integrated Oncology (CIO)   •  Cologne Center for Rare Diseases • Else Kröner Forschungskolleg Cologne  •  Mildred Scheel School of Oncology (MSSO) Cologne Bonn  •  Clinical Trials Centre Cologne (ZKS Köln)  •  Cologne Center for Genomics  •  Center for Data and Simulation Science • University Hospital Cologne • ORPHEUS  •  BioRiver - Life Science im Rheinland e.V.  •  Cologne Convention Bureau